drdavidwjg Profile Banner
Dr David Griffin 🦠🧫💉 Profile
Dr David Griffin 🦠🧫💉

@drdavidwjg

Followers
1K
Following
9K
Media
301
Statuses
2K

👨🏼‍🎓BSc, MBBS, MPH, FRACP👨🏼‍⚕️Infectious Diseases Doc, PhD Candidate. Interests: #HIV, #BBV, #TxID, #IPC, #Vaccines (#IDTwitter), 🇦🇺🇩🇪🏳️‍🌈 he/him

Melbourne, Victoria
Joined September 2015
Don't wanna be here? Send us removal request.
@drdavidwjg
Dr David Griffin 🦠🧫💉
1 year
Privileged to share some of my #PhD work at #HIVAIDS2024 @ASHMMedia looking at barriers to organ transplant for people with #HIV in Australia. Thanks @jennyhoy2 and @j_h_mcmahon for the guidance and pictures, collaborators, community, and participants.
1
3
35
@JAMA_current
JAMA
24 days
Syphilis is an infectious disease caused by Treponema pallidum, a gram-negative spirochete bacterium. This Review summarizes the epidemiology, diagnosis, treatment, and prevention of #syphilis. https://t.co/MRqBSaHf91
1
101
251
@AliSMV7
Alí Sebastian Meza
2 months
Aspergillus fumigatus biology, immunopathogenicity and drug resistance https://t.co/NkwxdMUpCm
0
18
48
@drdavidwjg
Dr David Griffin 🦠🧫💉
2 months
@drdavidwjg
Dr David Griffin 🦠🧫💉
2 months
1/ Pleased to share results of our discrete choice experiment of the influence of HIV on organ procurement and allocation in Australia #ASHM2025 @ASHMMedia @AlfredMonash_ID #healthequity #idtwitter #hivtwitter #TxIDtwitter
0
0
0
@drdavidwjg
Dr David Griffin 🦠🧫💉
2 months
In our study, #HIV has minimal influence on organ allocation in respondents, but is a significant barrier to the selection of a potential donor, even an appropriate recipient. Organ quality was the most influential factor in selection of a prospective donor.
0
0
0
@drdavidwjg
Dr David Griffin 🦠🧫💉
2 months
1/ Pleased to share results of our discrete choice experiment of the influence of HIV on organ procurement and allocation in Australia #ASHM2025 @ASHMMedia @AlfredMonash_ID #healthequity #idtwitter #hivtwitter #TxIDtwitter
1
1
3
@drkeithsiau
Keith Siau
3 months
Diagnostic criteria for MASLD and progression to cirrhosis - check out this 🆕 NEJM review ⭐️💡 📸: https://t.co/SjFUCkrxt3
2
98
356
@drdavidwjg
Dr David Griffin 🦠🧫💉
3 months
0
0
4
@drdavidwjg
Dr David Griffin 🦠🧫💉
3 months
Every Body Has Value: Ending Discriminatory Restrictions on Anatomical Donations
Tweet card summary image
academic.oup.com
Abstract. Anatomical body donation plays a critical role in medical education and scientific discovery. Yet, most programs in the United States continue to
0
0
4
@CIDJournal
Clinical Infectious Diseases
3 months
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19 ✅ Just Accepted 🔗 https://t.co/bjwBimNKq2
1
39
76
@BOOSTICStudy
BOOST-IC
4 months
#OpenAccess @BMC_series #Trials #statstwitter looking for the details of how we’re analysing @BOOSTICStudy? #BOOSTIC: Statistical elements and design, lead by @mdymock25 @drdavidwjg @j_h_mcmahon @MonashUni @AlfredHealth https://t.co/sLeeYiJ9ao
0
1
4
@AliSMV7
Alí Sebastian Meza
6 months
An Evidence-Based Approach to Covid-19 Vaccination https://t.co/qwu3DxCy0a
0
14
45
@drdavidwjg
Dr David Griffin 🦠🧫💉
6 months
@AliSMV7
Alí Sebastian Meza
6 months
Is an 8-week treatment strategy feasable in pulmonary TB? Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB) https://t.co/xgY5IxzQ8h
0
0
1
@BradSpellberg
Brad Spellberg
7 months
Wow! If anyone ever doubts the power of crowd sourcing, look at the vaccine RCT table that has been built already, in under 24 h! Unbelievable work by @jakescottMD Dr. Abhay Dand, @alejodiaz81 and Dr. Ali Sebastian Meza Vazquez! https://t.co/8Q3LiK8CJ2
18
48
129
@NEJM
NEJM
7 months
Treatments for mpox are needed. In this trial in the Democratic Republic of Congo, tecovirimat did not lead to faster resolution of mpox lesions than placebo in patients with clade I MPXV infection. Read the full PALM007 trial results: https://t.co/R8W9qHlhL9 Editorial:
2
17
50
@AliSMV7
Alí Sebastian Meza
7 months
Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva,Switzerland https://t.co/CxDDA8KpRe
0
6
30
@bryan_p_white
Bryan White
7 months
SNAP/COLCEBA trial session starting now @syctong @Josh_S_Davis @ABsteward Staph aureus causes 1 million deaths per year worldwide. Less than 4.5k randomized in staph aureus bacteremia. Randomized care is better than random care. SNAP platform started on a napkin. #ESCMIDGlobal
5
35
80
@NEJM
NEJM
7 months
In the PURPOSE 2 phase 3 trial, the incidence of HIV infection with twice-yearly lenacapavir was lower than both the background incidence and the incidence with emtricitabine–tenofovir disoproxil fumarate. Full trial results and Research Summary: https://t.co/yu3izOptLS
1
33
104
@syctong
Steven Tong
7 months
New review article on management of S. aureus bacteraemia: https://t.co/3XlIOb6rUu @JAMA_current Check out the gorgeous Figure which brings together elements of pathogenesis and management: (thread)
Tweet card summary image
jamanetwork.com
This narrative review summarizes current evidence on the epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment of Staphylococcus aureus bacteremia.
3
76
223